MTST
Price:
$0.0007
Market Cap:
$4.11K
MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatom...[Read more]
Industry
Biotechnology
IPO Date
2009-01-05
Stock Exchange
OTC
Ticker
MTST
According to MetaStat, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.95% compared to the average of -22.17 of the last 4 quarters.
The mean historical PE Ratio of MetaStat, Inc. over the last ten years is -361.94. The current -0.01 PE Ratio has changed -99.72% with respect to the historical average. Over the past ten years (40 quarters), MTST's PE Ratio was at its highest in in the February 2014 quarter at 632.38. The PE Ratio was at its lowest in in the November 2011 quarter at -3719.18.
Average
-361.94
Median
-76.67
Minimum
-1459.73
Maximum
-7.02
Discovering the peaks and valleys of MetaStat, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 306.81%
Maximum Annual PE Ratio = -7.02
Minimum Annual Increase = -93.14%
Minimum Annual PE Ratio = -1459.73
| Year | PE Ratio | Change |
|---|---|---|
| 2018 | -20.98 | 38.70% |
| 2017 | -15.12 | 115.33% |
| 2016 | -7.02 | -67.82% |
| 2015 | -21.83 | -59.03% |
| 2014 | -53.27 | -81.63% |
| 2013 | -289.97 | 189.73% |
| 2012 | -100.08 | -93.14% |
| 2011 | -1459.73 | 10.12% |
| 2010 | -1325.53 | 306.81% |
| 2009 | -325.83 | -91.96% |
The current PE Ratio of MetaStat, Inc. (MTST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-14.38
5-year avg
-23.64
10-year avg
-361.94
MetaStat, Inc.’s PE Ratio is less than OncoSec Medical Incorporated (-0.00), less than Rosetta Genomics Ltd. (-0.00), less than Adhera Therapeutics, Inc. (-0.00), less than Cardax, Inc. (-0.00), less than Modern Technology Corp. (-0.00), less than Motus GI Holdings, Inc. (-0.00), greater than Cannabiz Mobile, Inc. (-8.64), less than Nabriva Therapeutics plc (-0.00), less than Eloxx Pharmaceuticals, Inc. (-0.00), less than Sunset Island Group, Inc. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $596.00 | |
| -0.00 | $593.00 | |
| -0.00 | $722.00 | |
| -0.00 | $80.00 | |
| -0.00 | $441.00 | |
| -0.00 | $639.00 | |
| -8.64 | $50.00 | |
| -0.00 | $323.00 | |
| -0.00 | $314.00 | |
| -0.00 | $522.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MetaStat, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MetaStat, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is MetaStat, Inc.'s PE Ratio?
How is the PE Ratio calculated for MetaStat, Inc. (MTST)?
What is the highest PE Ratio for MetaStat, Inc. (MTST)?
What is the 3-year average PE Ratio for MetaStat, Inc. (MTST)?
What is the 5-year average PE Ratio for MetaStat, Inc. (MTST)?
How does the current PE Ratio for MetaStat, Inc. (MTST) compare to its historical average?